Mostrando 1 - 20 Resultados de 128 Para Buscar 'Lama (person)', tiempo de consulta: 0.60s Limitar resultados
  1. 1
    por Hizawa, Nobuyuki
    Publicado 2015
    “…In the combined use of bronchodilators of different classes, ie, long-acting β(2)-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs), bronchodilation is obtained both directly, through LABA-mediated stimulation of β(2)-adrenergic receptors, and indirectly, through LAMA-mediated inhibition of acetylcholine action at muscarinic receptors. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 2
    “…Attaining longevity was associated with the combinations LAMA2*ID + CDH4*D (OR = 2.23, P(Bonf) = 1.90 × 10(−2)) and CDH4*DD + LAMA2*ID + HECW1*D (OR = 4.58, P(Bonf) = 9.00 × 10(−3)) among persons aged between 18 and 89 years, LAMA2*ID + CDH4*D + SEMA6A*I for individuals below 75 years of age (OR = 3.13, P(Bonf) = 2.00 × 10(−2)), LAMA2*ID + HECW1*I for elderly people aged 60 and older (OR = 3.13, P(Bonf) = 2.00 × 10(−2)) and CDH4*DD + LAMA2*D + HECW1*D (OR = 4.21, P(Bonf) = 2.60 × 10(−2)) and CDH4*DD + LAMA2*D + ACE*I (OR = 3.68, P(Bonf) = 1.90 × 10(−2)) among old seniors (75–89 years old). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 3
  4. 4
  5. 5
    “…Results: a total of 2444 patients were assigned to the LAMA or ICS/LABA groups. The incidences of triple combination therapy in the LAMA and ICS/LABA groups were 81.0 and 139.8 per 1000 person-years, respectively (p < 0.001); the median times to triple therapy escalation were 281 and 207 days, respectively (p = 0.03). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
    por Li, Na, Zhan, Xianquan
    Publicado 2019
    “…RELEVANCE: The pathogenesis and biomarkers of ovarian cancer (OC) remain not well-known in diagnosis, effective therapy, and prognostic assessment in OC personalized medicine. The novel identified lncRNA and mRNA biomarkers from gene co-expression modules associated with clinical traits provide new insight for effective treatment of ovarian cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 20
Herramientas de búsqueda: RSS